Skip to main content
 CHANGE IN VISITATION GUIDELINES: Please read before visiting Rutgers Cancer Institute.
Menu

Herranz Laboratory News

December 12, 2021Dr. Herranz presenting at the 2022 ASH Annual Meeting

November 29, 2021 – Dr. Herranz selected as a 2022 AACR NextGen Star

October 14, 2021 – Dr. Herranz publishes editorial comment in Haematologica

September 27, 2021 – Komal Mandleywala rotating in the Herranz Lab

September 14, 2021 – Dr. Herranz recognized as a world-expert in T-ALL by Expertscape

July 24, 2021 – Maria Victoria da Silva-Diz receives the FASEB Abstract Award and at the FASEB Hematological Malignancies conference

July 23, 2021 – Luca Tottone receives the FASEB Outstanding Abstract Award and at the FASEB Hematological Malignancies conference

July 1, 2021 – Patricia Renck Nunes is awarded a postdoctoral fellowship from NJCCR

July 1, 2021The Herranz Lab receives prestigious AACR-Bayer Cancer Discovery and Innovation Grant

June 15, 2021 – The Herranz Lab receives funding from the Ludwig Institute for Cancer Research (Princeton Branch)

April 19, 2021 – The Herranz Lab publishes in Blood
                            A novel and highly effective mitochondrial uncoupling drug in T-cell leukemia

March 15, 2021 – Dr. Herranz invited to present at the Josep Carreras Leukaemia Research Institute
                             (“The Immune System: in sickness and in health” Symposium)

January 1, 2021 – The Herranz Lab collaborates with the Maraver Lab to publish a paper in Theranostic

December 24, 2020 – Herranz’s Lab study published in Leukemia selected as a highlight of the year by the NCI

November 20, 2020 – The Herranz Lab publishes in Blood Cancer Discovery
                                     A tumor suppressor enhancer of PTEN in T-cell development and leukemia

June 24, 2020 – Dr. Herranz gives an oral presentation at the 2020 AACR Annual Meeting

May 07, 2020 - Herranz lab collaborates with the Rabinowitz Lab (Princeton) to publish a research article in Leukemia
SHMT inhibition is effective and synergizes with methotrexate in T-cell acute lymphoblastic leukemia.

May 01, 2020 – Herranz lab welcomes postdoctoral fellow Patricia Renck Nunes, PhD

January 01, 2020 – Luca Tottone is awarded a postdoctoral fellowship from NJCCR

January 01, 2020 – American Cancer Society funds the grant: The role of SIRT1 in T-Cell Acute Lymphoblastic Leukemia

December 16, 2019 – Alex’s Lemonade Stand Foundation funds the grant: “Novel metabolic and epigenetic therapies in T-ALL”

October 08, 2019 - Herranz lab presents its research at Memorial Sloan Kettering Cancer Center

November 19, 2019  - NJBIZ reports that the Rutgers Cancer Institute has received a $2.3M grant from the American Cancer Society for research into cell metabolism and tumor formation in forms of breast cancer, lung cancer and leukemia.

September 24, 2019 - Herranz lab presents its research at Hackensack Meridian Health Center for Discovery and Innovation

September 23, 2019 - Herranz lab welcomes Matt Lawlor as a rotating graduate student

September 13. 2019 - Herranz lab collaborates with the Ferrando lab (Columbia University) to publish an article in Cancer Discovery: Gata3-controlled nucleosome eviction drives Myc enhancer activity in T-cell development and leukemia.

August 1, 2019 - Herranz lab welcomes Naureen Hameed as a rotating graduate student

July 17, 2019 More than $2 million in grants recently awarded to Rutgers Cancer Institute of New Jersey resident researcher Daniel Herranz Benito, PhD, will support examination of potential treatment targets for a rare and aggressive blood cancer

July 1, 2019 - NIH/NCI funds R01 grant: The role of glutaminolysis as a therapeutic tatget in T-ALL

June 17, 2019 – Herranz lab presents its research at the National Cancer Institute (NCI)

April 2, 2019 - Gabrielle’s Angel Foundation for Cancer Research funds the Herranz Lab to analyze the role of Sirt1 in the pathogenesis and treatment of T-ALL

February 26, 2019 - Maria Victoria da Silva-Diz is awarded a postdoctoral fellowship from NJCCR

February 8, 2019 - Children’s Leukemia Research Association funds the Herranz Lab to investigate the metabolic and transcriptional effects of Sirt1 in T-ALL

December 3, 2018  - Alex’s Lemonade Stand Foundation funds the Herranz Lab through their Alex’s Million Mile grants to investigate novel therapeutic targets in T-ALL

November 2, 2018 - Herranz lab publishes a review paper with Olga Lancho as first author in Trends in Cancer:

The MYC Enhancer-ome: Long-Range Transcriptional Regulation of MYC in Cancer.

October 8, 2018  - Mihir Desai joins the Herranz Lab as a rotating undergrad

September 29, 2018  - Herranz lab presents its research at the AACR Special Conference on Metabolism and Cancer (Brooklyn, New York)

July 18, 2018 - Herranz lab collaborates with the Serrano Lab (IRB/CNIO) and the Fernandez-Marcos Lab (IMDEA) to publish a research article in EMBO Reports: Sirt1 protects from K-Ras-driven lung carcinogenesis.

July 1, 2018  - Leukemia Research Foundation funds the Herranz Lab to investigate the role of PKM2 in leukemia

June 4, 2018  - Herranz lab presents its research at Spanish National Cancer Center (CNIO), Madrid (Spain)

May 29, 2018 - Herranz lab welcomes Shirley Luo as our new Lab Manager

May 1, 2018  - Herranz lab welcomes postdoctoral fellow Maria Victoria da Silva-Diz, PhD

March 15, 2018  - Herranz lab welcomes postdoctoral fellow Luca Tottone, PhD

December 20, 2017 - Herranz lab presents its research at IMDEA Food Institute, Madrid (Spain)

December 18, 2017 - Herranz lab presents its research at Institut de Recherche en Cancérologie de Montpellier, INSERM (France)

October 2, 2017  - Herranz lab welcomes postdoctoral fellow Olga Lancho, PhD

September 9, 2017 -  Alex’s Lemonade Stand Foundation funds the Herranz Lab through their Shark Tank Award

July 2, 2017 - NIH/NCI funds R00 grant: Functional Dissection of Oncogenic Enhancers

July 1, 2017 - Herranz Lab opens at Rutgers Cancer Institute of New Jersey